- Open Access
Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands
BMC Pulmonary Medicine volume 16, Article number: 105 (2016)
- The original article was published in BMC Pulmonary Medicine 2016 16:80
The original version of this article  unfortunately contained errors that have since been corrected.
The word “pharmo” has been fully capitalised to “PHARMO” throughout the article.
The reference to Table 2 in the first and second sentence under the Outcomes heading has been replaced with Fig. 3.
Under the Abbreviations heading ‘extrafine-particle’ was repeated, this has been corrected to ‘EF-HFA-BDP [Qvar®]: extrafine-particle hydrofluoroalkane beclomethasone dipropionate’.
The competing interests of Nicolas Roche and Theresa Guibert have been amended.
Academic affiliations for Dirkje S. Postma (2), Richard J. Martin (3), Ron M.C. Herrings (4), Jetty Overbeek (4), and Nicolas Roche (7) have been corrected.
Figure 3 in the online and pdf version did not match, this been amended.
van der Molen T, et al. BMC Pulm Med. 2016;16:80. doi:10.1186/s12890-016-0234-0.
The online version of the original article can be found under doi:10.1186/s12890-016-0234-0.
About this article
Cite this article
van der Molen, T., Postma, D.S., Martin, R.J. et al. Erratum to: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands. BMC Pulm Med 16, 105 (2016). https://doi.org/10.1186/s12890-016-0270-9